WEDNESDAY, Sept. 6, 2017 (HealthDay News) — A “biologic” drug in development to treat severe asthma reduces the rate of serious attacks by about two-thirds compared to a placebo drug, according to preliminary research findings.

If approved, the drug, tezepelumab, could join a group of costly medications that appear to offer relief when nothing else curbs respiratory distress.

“A new era has begun in which many new drugs are being developed for patients with severe asthma,” said Dr….

Continue reading on Health

Leave a Reply

Your email address will not be published.